北美慢性疾病管理市场,按类型(解决方案和服务)、解决方案类型(本地解决方案、基于云的解决方案、基于 Web 的解决方案)、服务类型(教育服务、实施服务、咨询服务和其他)、疾病指征(心血管疾病 (CVD)、糖尿病、慢性阻塞性肺病 (COPD)、关节炎、哮喘、癌症和其他)、最终用户(医疗保健提供者、医疗保健付款人、其他)、国家(美国、加拿大、墨西哥)划分,行业趋势和预测至 2028 年
市场分析和洞察:北美慢性病管理市场
北美慢性病管理市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称,在 2021 年至 2028 年的预测期内,该市场的复合年增长率为 15.6%,预计到 2028 年将达到 67.6412 亿美元。慢性病患病率的上升需要先进的慢性病管理解决方案和服务,从而成为慢性病管理市场增长的驱动力。
慢性病管理 (CDM) 是一种持续的护理和支持,旨在为患有慢性疾病的个人提供他们所需的医疗护理、知识、技能和资源,以便更好地管理日常生活。它主要由各种软件和服务提供。慢性病管理通过综合护理预防或尽量减少疾病的影响,有助于降低医疗保健成本并改善慢性病患者的生活质量。
老年人口的增加和慢性病患病率的上升是慢性病管理市场发展的驱动力。对基于云的解决方案的安全担忧降低了慢性病管理解决方案的需求,从而限制了慢性病管理市场的增长。新技术进步的激增为慢性病管理市场带来了机遇。然而,中低收入国家缺乏可及性,这对慢性病管理市场的增长构成了挑战。
北美慢性病管理市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息,分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和慢性病管理市场情景,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您创建收入影响解决方案,以实现您的预期目标。
慢性病管理市场范围和市场规模
The chronic disease management market is segmented on the based on the type, solution type, service type, disease indication and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the chronic disease management market is segmented into solution and services. In 2021, solution segment is expected to dominate the chronic disease management market due to rising geriatric populace.
- On the basis of solution type, the chronic disease management market is segmented into on-premise solution, cloud-based solution and web-based. In 2021, on premise solution vectors segment is expected to dominate the chronic disease management market due to rising adoption on premise solution.
- On the basis of service type, the chronic disease management market is segmented into education service, implementation service, consulting service and others. In 2021, Implementation Services segment is expected to dominate the chronic disease management market due to rising strategic initiatives by key players.
- On the basis of disease indication, the chronic disease management market is segmented into cardiovascular diseases (CVD), diabetes, chronic obstructive pulmonary disorders (COPD), arthritis, asthma, cancer and others. In 2021, cardiovascular diseases (CVD) segment is expected to dominate the chronic disease management market due to rising incidence of chronic diseases.
- On the basis of end user, the chronic disease management market is segmented into healthcare providers, healthcare payers, others. In 2021, healthcare providers segment is expected to dominate the chronic disease management market due to rising pace of early diagnosis and screening.
Chronic Disease Management Market Country Level Analysis
The chronic disease management market is analyzed and market size information is provided by the country, type, solution type, service type, disease indication and end user as referenced above.
The countries covered in the North America chronic disease management market report are the U.S., Canada and Mexico.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growing Strategic Activities by Major Market Players to Enhance the Awareness for Chronic Disease Management is Boosting the Market Growth of Chronic Disease Management market.
The chronic disease management market also provides you with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.
Competitive Landscape and Chronic Disease Management Market Share Analysis
Chronic disease management market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Chronic Disease Management market.
The major companies which are dealing in the North America chronic disease management are Koninklijke Philips N.V., WellSky, ZeOmega, Health Catalyst, Cedar Gate Technologies, Cognizant, Pegasystems Inc., Epic Systems Corporation, Hinduja Global Solutions Ltd., NXGN Management, LLC, MINES & Associates, Inc., Casenet, LLC, ExlServings Holdings, Inc., cliexa, Inc., ScienceSoft USA Corporation, Vivify Health, Inc., Allscripts Healthcare, LLC., Infosys Limited, Medecision, IBM corporation, Altruista Health and TCS Healthcare Technologies among others domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many contract and agreement are also initiated by the companies’ worldwide which are also accelerating the North America chronic disease management market.
For instance,
- In April 2021, WellSky launched advanced home health visit management solution. The new addition CareInsights Guidance provides actionable visit utilization insights to balance the care quality and patient health improvement. It is predicted that, this solution launch will provide benefits to their patients, staff, and leading to upsurge the sales growth of the company.
- In December 2020, HGS AxisPoint Health (a subsidiary of Hinduja Global Solutions Ltd.), partnered with Parkland Community Health Plan (PCHP). The primary purpose of this partnership was to supply disease management services to approximately 195,000 Medicaid beneficiaries in North Texas. This enhanced the company’s presence in global market, leading to upsurge the sales growth of the company.
市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业和其他策略正在增强公司在慢性疾病管理市场的影响力,这也为组织的利润增长带来了好处。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET END USER COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: REGULATIONS
5.1 REGULATION IN THE UNITED STATES:
5.2 GOVERNING REGULATIONS:
5.3 CPT CODES:
5.4 PRACTITIONER ELIGIBILITY:
5.5 PATIENT ELIGIBILITY:
5.6 REQUIREMENTS:
5.7 REGULATIONS IN EUROPE:
5.8 NATIONAL STRATEGY AND LEAD ORGANIZATIONS FOR HEALTHCARE SERVICES IN EUROPE:
5.9 DATA PRIVACY PROTECTION IN EUROPE:
5.1 REGULATIONS IN INDIA:
5.11 RELEVANT ACTS FOR THIS FRAMEWORK:
5.12 DATA PRIVACY PROTECTION IN INDIA:
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
6.1.2 GROWING GERIATRIC POPULATION
6.1.3 RISING PER CAPITA INCOME
6.1.4 ADVANCEMENT IN HEALTHCARE INFRASTRUCTURE AND INITIATIVE ACTIVITIES BY GOVERNMENT ORGANIZATION
6.2 RESTRAINTS
6.2.1 HIGH COST OF SERVICES
6.2.2 SECURITY CONCERNS WITH CLOUD-BASED SOLUTIONS
6.3 OPPORTUNITIES
6.3.1 SURGE IN NOVEL TECHNOLOGICAL ADVANCEMENTS
6.3.2 RISING HEALTHCARE EXPENDITURE
6.3.3 INCREASED REIMBURSEMENT POLICIES
6.3.4 RISING DISEASE MANAGEMENT PROGRAMS
6.4 CHALLENGE
6.4.1 LACK OF ACCESSIBILITY
7 IMPACT OF COVID-19 ON THE NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS
7.4 CONCLUSION
8 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE
8.1 OVERVIEW
8.2 SOLUTION
8.3 SERVICES
9 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE
9.1 OVERVIEW
9.2 ON PREMISE SOLUTION
9.3 WEB BASED SOLUTION
9.4 CLOUD BASED SOLUTION
10 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICES TYPE
10.1 OVERVIEW
10.2 IMPLEMENTATION SERVICES
10.3 CONSULTING SERVICES
10.4 EDUCATION SERVICES
10.5 OTHERS
11 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION
11.1 OVERVIEW
11.2 CARDIOVASCULAR DISEASES (CVD)
11.3 DIABETES
11.4 CHRONIC OBSTRUCTIVE PULMONARY DISORDERS (COPD)
11.5 ASTHMA
11.6 ARTHRITIS
11.7 CANCER
11.8 OTHERS
12 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER
12.1 OVERVIEW
12.2 HEALTHCARE PROVIDERS
12.2.1 HOSPITALS, PHYSICIAN GROUPS, INTEGRATED DELIVERY
12.2.2 DIAGNOSTIC & IMAGING CENTERS
12.2.3 AMBULATORY CARE CENTERS
12.2.4 HOME HEALTHCARE AGENCIES, NURSING HOMES & ASSISTED LIVING FACILITIES
12.2.5 OTHERS
12.3 HEALTHCARE PAYERS
12.3.1 PUBLIC PAYERS
12.3.2 PRIVATE PAYERS
12.4 OTHERS
13 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET BY REGION
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 COMPANY PROFILES
16.1 IBM CORPORATION
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 SERVICE PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 KONINKLIJKE PHILIPS N.V.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 COGNIZANT
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 ALLSCRIPTS HEALTHCARE, LLC
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 SOLUTION PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 ALTRUISTA HEALTH
16.5.1 COMPANY SNAPSHOT
16.5.2 SOLUTION PORTFOLIO
16.5.3 RECENT DEVELOPMENTS
16.6 CASENET, LLC
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT & SERVICE PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 CEDAR GATE TECHNOLOGIES
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
16.8 CLIEXA, INC.
16.8.1 COMPANY SNAPSHOT
16.8.2 SOLUTION PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 EPIC SYSTEMS CORPORATION
16.9.1 COMPANY SNAPSHOT
16.9.2 SERVICE PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 EXLSERVICE HOLDINGS, INC.
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 SERVICE PORTFOLIO
16.10.4 RECENT DEVELOPMENTS
16.11 HEALTH CATALYST
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 PRODUCT PORTFOLIO
16.11.4 RECENT DEVELOPMENT
16.12 HINDUJA NORTH AMERICA SOLUTIONS LTD.
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPMENTS
16.13 INFOSYS LIMITED
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 SOLUTION PORTFOLIO
16.13.4 RECENT DEVELOPMENTS
16.14 MEDECISION
16.14.1 COMPANY SNAPSHOT
16.14.2 SOLUTION PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 MINES & ASSOCIATES, INC.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 NXGN MANAGEMENT, LLC
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.17 PEGASYSTEMS INC.
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 SCIENCESOFT USA CORPORATION
16.18.1 COMPANY SNAPSHOT
16.18.2 INDUSTRY PORTFOLIO
16.18.3 RECENT DEVELOPMENTS
16.19 TCS HEALTHCARE TECHNOLOGIES
16.19.1 COMPANY SNAPSHOT
16.19.2 SERVICE PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 VIVIFY HEALTH, INC.
16.20.1 COMPANY SNAPSHOT
16.20.2 SOLUTION PORTFOLIO
16.20.3 RECENT DEVELOPMENTS
16.21 WELLSKY
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENTS
16.22 ZEOMEGA
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
表格列表
TABLE 1 NUMBER OF PEOPLE WITH DIABETES AMONG 20–79 YEARS OLD (IN MILLION)
TABLE 2 NEW CANCER CASES FOR AGE 85+ IN THE U.S.
TABLE 3 PER CAPITA AMOUNTS: THE UNITED STATES (1960–2017)
TABLE 4 PRICES OF ESSENTIAL CHRONIC DISEASE MANAGEMENT SOLUTIONS
TABLE 5 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA ON PREMISE SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA WEB BASED SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA CLOUD BASED SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICES TYPE, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA IMPLEMENTATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA CONSULTING SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA EDUCATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA EDUCATION SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA CARDIOVASCULAR DISEASES (CVD) IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA DIABETES IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA CHRONIC OBSTRUCTIVE PULMONARY DISORDERS (COPD) IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA ASTHMA IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA ARTHRITIS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA CANCER IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA OTHERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA HEALTHCARE ROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA HEALTHCARE ROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA OTHERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 39 U.S. CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 40 U.S. SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 41 U.S. SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 42 U.S. CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 43 U.S. CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 U.S. HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 45 U.S. HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 46 CANADA CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 47 CANADA SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 48 CANADA SERVICE TYPE IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 49 CANADA CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 50 CANADA CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 51 CANADA HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 52 CANADA HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 53 MEXICO CHRONIC DISEASE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 54 MEXICO SOLUTION IN CHRONIC DISEASE MANAGEMENT MARKET, BY SOLUTION TYPE, 2019-2028 (USD MILLION)
TABLE 55 MEXICO SERVICES IN CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 56 MEXICO CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 57 MEXICO CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 58 MEXICO HEALTHCARE PROVIDERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 59 MEXICO HEALTHCARE PAYERS IN CHRONIC DISEASE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: MARKET END USER COVERAGE GRID
FIGURE 11 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: SEGMENTATION
FIGURE 12 GROWING GERIATRIC POPULATION IS EXPECTED TO DRIVE THE NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 SOLUTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET
FIGURE 15 PREVALENCE OF CHRONIC DISEASES
FIGURE 16 AGING POPULATION IN THE WORLD (IN MILLIONS)
FIGURE 17 NORTH AMERICA AGING POPULATION (IN MILLIONS)
FIGURE 18 EUROPE AGING POPULATION (IN MILLIONS)
FIGURE 19 ASIA-PACIFIC AGING POPULATION (IN MILLIONS)
FIGURE 20 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, 2020
FIGURE 21 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, 2019-2028 (USD MILLION)
FIGURE 22 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 23 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 24 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, 2020
FIGURE 25 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, 2019-2028 (USD MILLION)
FIGURE 26 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, CAGR (2021-2028)
FIGURE 27 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY SOLUTION TYPE, LIFELINE CURVE
FIGURE 28 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, 2020
FIGURE 29 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, 2019-2028 (USD MILLION)
FIGURE 30 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, CAGR (2021-2028)
FIGURE 31 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY SERVICES TYPE, LIFELINE CURVE
FIGURE 32 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, 2020
FIGURE 33 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, 2019-2028 (USD MILLION)
FIGURE 34 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, CAGR (2021-2028)
FIGURE 35 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY DISEASE INDICATION, LIFELINE CURVE
FIGURE 36 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, 2020
FIGURE 37 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, 2019-2028 (USD MILLION)
FIGURE 38 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, CAGR (2021-2028)
FIGURE 39 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 40 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: SNAPSHOT (2020)
FIGURE 41 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2020)
FIGURE 42 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 43 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 44 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: BY TYPE (2021-2028)
FIGURE 45 NORTH AMERICA CHRONIC DISEASE MANAGEMENT MARKET: COMPANY SHARE 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.